Skip to main content
Clinical Trials/CTRI/2025/03/081640
CTRI/2025/03/081640
Not yet recruiting
Phase 4

Comparative evaluation of the effects of injectable-platelet rich fibrin (I-PRF) and synthetic graft on the implant stability following indirect sinus augmentation

Dr Sunaina M1 site in 1 country30 target enrollmentStarted: March 31, 2025Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Dr Sunaina M
Enrollment
30
Locations
1
Primary Endpoint
To assess the implant stability following indirect sinus augmentation using Injectable-Platelet Rich Fibrin (I-PRF), synthetic graft and without graft

Overview

Brief Summary

This study aims to assess and compare the effects of Injectable-Platelet-Rich Fibrin(I-PRF) and synthetic graft on the implant stability following indirect sinus augmentation. The study will include 30 participants with missing maxillary posterior teeth and a minimum of 4mm residual bone height and 6mm crestal bone width. Participants will be divided into 3 groups of 10 each. In Group 1, participants will undergo sinus membrane elevation without graft. For Group 2, participants will undergo sinus membrane elevation and Injectable-Platelet Rich Fibrin (I-PRF) will be used for augmentation. In Group 3, participants will undergo sinus membrane elevation and synthetic graft material will be used for augmentation. Appropriate implant will be selected and placed depending on the parameters of the participant’s native bone. Implant stability will be measured using resonance frequency analysis (RFA) device at the time of implant placement and at 6 months. The values will be noted in the data collection sheet. Statistical analysis will be done accordingly and obtained data will be used to find the association between 3 groups.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
19.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Participants will be selected using the following criteria:
  • Healed edentulous ridge in the maxillary pre-molar or molar region.
  • Residual bone height ranging from 4 to 6 mm.
  • Crestal bone width ranging from 6 to 8 mm.
  • Maintaining Good oral hygiene.

Exclusion Criteria

  • Systemic conditions such as uncontrolled diabetes mellitus, hypertension and bleeding disorder
  • Presence of active sinusitis
  • Sinus membrane thickening of more than 2mm
  • Patients on long term steroid therapy or bisphosphonate medication
  • Any previous history of sinus surgery
  • Untreated active periodontitis in neighbouring teeth
  • Participants who are current smokers
  • Pregnant women and nursing mothers.

Outcomes

Primary Outcomes

To assess the implant stability following indirect sinus augmentation using Injectable-Platelet Rich Fibrin (I-PRF), synthetic graft and without graft

Time Frame: at baseleine, at 6 months after implant placement

Secondary Outcomes

  • To compare the stability of the implant following indirect sinus augmentation using Injectable-Platelet Rich Fibrin (I-PRF), synthetic graft & without bone graft.(At baseline & after 6 months after implant placement)

Investigators

Sponsor
Dr Sunaina M
Sponsor Class
Other [self funding]
Responsible Party
Principal Investigator
Principal Investigator

Dr Sunaina M

Yenepoya Dental College

Study Sites (1)

Loading locations...

Similar Trials